bpc 157 peptide benefits risks FDA panel votes to ease restrictions on an unregulated BPC-157 BPC-157: A Prohibited Peptide and

ncbi.nlm.nih.gov/pmc/articles/PMC7345585 U.S

Caution is advised in patients with Leber optic atrophy, a genetic disorder caused by chronic cyanide intoxication (such as from smoking, alcohol or some plants), against the use of cyano-B12 due to its cyanide moiety, whilst hydroxo-B12 is a cyanide antagonist and can therefore be used in these patients

Benefits have also been shown in low back pain, autistic spectrum disorders and aphthous ulcers, although this is based on small numbers of clinical trials

Signs You May Need a Different B12 Dose Recognising when your current vitamin B12 dose may be inadequateor occasionally excessiveis important for maintaining optimal health and preventing complications

We avoid using tertiary references